Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

por Ulrich-Pur, H, Raderer, M, Verena Kornek, G, Schüll, B, Schmid, K, Haider, K, Kwasny, W, Depisch, D, Schneeweiss, B, Lang, F, Scheithauer, W
Publicado 2003

Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer

por Bauernhofer, T, Kuss, I, Friebe-Hoffmann, U, Baum, A S, Dworacki, G, Vonderhaar, B K, Whiteside, T L
Publicado 2003

Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer

por Matsumoto, H, Matsuyama, H, Fukunaga, K, Yoshihiro, S, Wada, T, Naito, K
Publicado 2004

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

por Campbell, H E, Taylor, M A, Harris, A L, Gray, A M
Publicado 2009

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial

por Ferrandina, G, Sallustio, G, Fagotti, A, Vizzielli, G, Paglia, A, Cucci, E, Margariti, A, Aquilani, L, Garganese, G, Scambia, G
Publicado 2009

Inhibition of constitutive and cxc-chemokine-induced NF-κB activity potentiates ansamycin-based HSP90-inhibitor cytotoxicity in castrate-resistant prostate cancer cells

por Seaton, A, Maxwell, P J, Hill, A, Gallagher, R, Pettigrew, J, Wilson, R H, Waugh, D J J
Publicado 2009

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer

por van Agthoven, T, Sieuwerts, A M, Veldscholte, J, Meijer-van Gelder, M E, Smid, M, Brinkman, A, den Dekker, A T, Leroy, I M, van IJcken, W F J, Sleijfer, S, Foekens, J A, Dorssers, L C J
Publicado 2009

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma

por El-Sahwi, K, Bellone, S, Cocco, E, Cargnelutti, M, Casagrande, F, Bellone, M, Abu-Khalaf, M, Buza, N, Tavassoli, F A, Hui, P, Silasi, D-A, Azodi, M, Schwartz, P E, Rutherford, T J, Pecorelli, S, Santin, A D
Publicado 2010

Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells

por Johansson, D, Andersson, C, Moharer, J, Johansson, A, Behnam-Motlagh, P
Publicado 2010

False-positive screening results in the Finnish prostate cancer screening trial

por Kilpeläinen, T P, Tammela, T L J, Määttänen, L, Kujala, P, Stenman, U-H, Ala-Opas, M, Murtola, T J, Auvinen, A
Publicado 2010

The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(−1)

por McGrath, S, Short, D, Harvey, R, Schmid, P, Savage, P M, Seckl, M J
Publicado 2010

Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma

por Kato, Y, Yashiro, M, Noda, S, Tendo, M, Kashiwagi, S, Doi, Y, Nishii, T, Matsuoka, J, Fuyuhiro, Y, Shinto, O, Sawada, T, Ohira, M, Hirakawa, K
Publicado 2010

Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells

por Shinto, O, Yashiro, M, Kawajiri, H, Shimizu, K, Shimizu, T, Miwa, A, Hirakawa, K
Publicado 2010

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

por Reid, A H M, Attard, G, Ambroisine, L, Fisher, G, Kovacs, G, Brewer, D, Clark, J, Flohr, P, Edwards, S, Berney, D M, Foster, C S, Fletcher, A, Gerald, W L, Møller, H, Reuter, V E, Scardino, P T, Cuzick, J, de Bono, J S, Cooper, C S
Publicado 2010

Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide

por Bray, J, Sludden, J, Griffin, M J, Cole, M, Verrill, M, Jamieson, D, Boddy, A V
Publicado 2010

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

por Zarate, R, Rodríguez, J, Bandres, E, Patiño-Garcia, A, Ponz-Sarvise, M, Viudez, A, Ramirez, N, Bitarte, N, Chopitea, A, Gacía-Foncillas, J
Publicado 2010

Age of mother and grandmother in relation to a subject's breast cancer risk

por de Haan, M C, Michels, K B, Peeters, P H M, van Noord, P A H, Hennekam, F A M, van der Schouw, Y T
Publicado 2010

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction

por Baneshi, M R, Warner, P, Anderson, N, Edwards, J, Cooke, T G, Bartlett, J M S
Publicado 2010

Patient satisfaction with GP-led melanoma follow-up: a randomised controlled trial

por Murchie, P, Nicolson, M C, Hannaford, P C, Raja, E A, Lee, A J, Campbell, N C
Publicado 2010

Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction

por Stingl, L, Stühmer, T, Chatterjee, M, Jensen, M R, Flentje, M, Djuzenova, C S
Publicado 2010